Arctic Bioscience AS (DE:9TD) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Arctic Bioscience CEO Christer Valderhaug has increased his stake in the company by purchasing an additional 10,000 shares, bringing his total to 57,630 shares. Arctic Bioscience is a biotech firm known for developing the psoriasis drug candidate HRO350 and selling dietary supplements globally under the ROMEGA® brand.
For further insights into DE:9TD stock, check out TipRanks’ Stock Analysis page.
